Jasper Therapeutics, Inc.JSPRNASDAQ

Revenue (LTM)

Net Income (LTM)

$-71M

-10.6% YoY

Free Cash Flow

$-63M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-21	-37↓78.1%	-51↓39.0%	-69↓34.5%	-76↓10.7%
Net Income	-32	-31↑3.3%	-38↓23.0%	-64↓71.1%	-71↓10.6%
EBITDA	0	-36	-50↓37.8%	-68↓34.9%	-75↓10.5%
EPS Diluted	-183.08	-26.89↑85.3%	-10.33↑61.6%	-6.18↑40.2%	-4.89↑20.9%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	20	85↑327.0%	38↓54.8%	87↑127.2%	72↓17.6%
Total Current Assets	21	88↑324.6%	42↓52.5%	89↑113.1%	76↓14.8%
Total Assets	23	94↑301.0%	48↓48.4%	95↑96.2%	80↓15.8%
Total Current Liabilities	4	8↑99.9%	7↓11.9%	12↑75.1%	15↑23.1%
Total Liabilities	58	24↓58.7%	12↓48.7%	16↑33.0%	18↑10.8%
Total Equity	-35	70↑297.9%	36↓48.2%	78↑118.0%	62↓21.4%
Total Debt	2	3↑77.6%	4↑26.6%	3↓23.7%	2↓34.9%
Net Debt	-18	-82↓349.2%	-35↑57.7%	-84↓143.1%	-70↑17.0%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-18	-34↓84.4%	-46↓36.2%	-52↓13.5%	-63↓20.2%
Capital Expenditure	0	-2	-1↑76.3%	-0↑53.6%	-1↓106.7%
Free Cash Flow	-18	-36↓97.7%	-46↓28.6%	-52↓12.7%	-63↓20.7%
Stock-Based Comp	1	1↓13.4%	0	5	7↑27.0%
Net Change in Cash	-7	65↑1029.3%	-46↓171.6%	49↑204.7%	-15↓131.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance